SCHEMBL5239795

SCHEMBL5239795

CCOC(=O)c1sccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.51
MAPK9 P45984 1/20 0.51
MAPK10 P53779 1/20 0.51
PKM P14618 2/20 0.50
ALDH1A1 P00352 4/20 0.49
HPGD P15428 3/20 0.49
GAA P10253 3/20 0.49
KDM4E B2RXH2 3/20 0.49
GLA P06280 1/20 0.49
MAPK1 P28482 1/20 0.49
MAPT P10636 5/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
NFKB1 P19838 1/20 0.48
STAT1 P42224 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5078857 0.89 TSHR (0.55) MAPK8MAPK9MAPK10PKMALDH1A1
SCHEMBL5240541 0.86 TSHR (0.52) MAPK8MAPK9MAPK10PKMALDH1A1
Hydrochloric Acid SCHEMBL27405490 0.85 TSHR (0.50) MAPK8MAPK9MAPK10PKMALDH1A1
SCHEMBL2996635 0.84 TSHR (0.53) PKMALDH1A1HPGDGAAKDM4E
SCHEMBL3053745 0.84 PKM (0.67) MAPK8MAPK9MAPK10PKMALDH1A1
SCHEMBL28807508 0.82 TSHR (0.55) ALDH1A1KDM4EMAPK1MAPTNPC1
SCHEMBL1973549 0.80 KDM4E (0.57) MAPK8MAPK9MAPK10PKMALDH1A1
SCHEMBL6058447 0.80 MAPK1 (0.43) PKMALDH1A1HPGDGAAKDM4E
SCHEMBL698811 0.80 ALDH1A1 (0.51) ALDH1A1HPGDGAAKDM4EGLA
SCHEMBL9710339 0.79 CA12 (0.52) MAPK8MAPK9MAPK10PKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116571280-A For CO 2 Cycloaddition reaction ionic metal-organic framework catalyst and preparation method and application thereof 辽宁师范大学 2023-08-11 CN claimed
CN-116571280-A For CO 2 Cycloaddition reaction ionic metal-organic framework catalyst and preparation method and application thereof 辽宁师范大学 2023-08-11 CN disclosed
CN-114561025-A Pyridinium-modified UiO-66 compound, preparation method and application 辽宁师范大学 2022-05-31 CN disclosed
EP-1355886-B1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2007-07-11 EP disclosed
US-7034039-B2 Fused heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-25 US disclosed
CN-1500080-A Fused heterocyclic compounds ����ҩƷ��ҵ��ʽ���� 2004-05-26 CN disclosed
US-20040082607-A1 Fused heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-29 US disclosed
EP-1355886-A1 FUSED HETEROCYCLIC COMPOUNDS Takeda Chemical Industries, Ltd. (JP) 2003-10-29 EP disclosed
WO-2002062764-A9 FUSED HETEROCYCLIC COMPOUNDS TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-10-10 WO disclosed
WO-2002062764-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-08-15 WO disclosed
EP-0267794-B1 PROCESS FOR PREPARING POLYOLEFINS Nippon Petrochemicals Co., Ltd. (JP) 1993-05-05 EP disclosed
US-4853149-A STABILITY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-08-01 US disclosed
EP-0267794-A2 Process for preparing polyolefins Nippon Petrochemicals Co., Ltd. (JP) 1988-05-18 EP disclosed
US-4525555-A TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS NIPPON OIL COMPANY, LIMITED (JP) 1985-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082607-A1 Fused heterocyclic compounds DPP7, DPP4, METAP1 MAPK8 2612/4885MAPK9 3393/4885MAPK10 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.